MoD · NATO · UKDI · Defence Procurement — Battlefield Medical Technology
DEFENCE &
PROCUREMENT.
Five devices. One protocol. Any soldier. The doctrinal gap that kills is the gap this fills.
The Problem
THE DOCTRINAL
GAP THAT KILLS.
Haemorrhagic shock kills 40% of potentially survivable combat casualties. The Eastridge et al. 2012 analysis of 4,596 combat deaths across Iraq and Afghanistan identified 887 potentially survivable haemorrhage deaths. These soldiers did not die because their wounds were unsurvivable.
They died in the gap. The gap between wounding and the arrival of a medic. The gap between the casualty's own limited interventions and the treatment they needed. Every existing prehospital stabilisation protocol assumes a trained medic is present. In large-scale combat operations against a peer adversary — the operational environment the British Army must now plan for — that assumption fails at scale.
NTL Programme Documentation
"The doctrinal gap is not a shortage of blood products. It is the absence of any intervention that the casualty or an untrained buddy can execute in the first two minutes after wounding — before anyone else arrives."
Defence Product Suite
FIVE DEVICES.
ONE PROTOCOL.
Five point-of-wounding devices executed in sequence in under two minutes by the casualty themselves or an untrained buddy. No medic. No cold chain. No clinical skill required. Every device is a UK patent application.
RAPIDPen
Dual-chamber auto-injectorTXA arrests coagulopathy. Sub-anaesthetic ketamine reduces mean arterial pressure 40–45%, cutting ongoing blood loss before volume replacement begins. Self-administered outer thigh through clothing. Two seconds. BinaJect dual-chamber platform (ATNAA precedent).
2 seconds · Outer thigh · Through clothingRAPIDPlasma
Frangible-membrane plasma unit500ml freeze-dried plasma. Bend to crack the internal frangible membrane. Shake to mix. No separate water. No syringe. No clinical skill. Reconstituted plasma ready in 2 minutes. No cold chain logistics requirement.
2 minutes · No cold chain · No skillRAPIDConnect
Pre-primed sterile transfer lineFactory-filled WFI to BP/EP monograph. Dual male Luer lock — compatible with all standard IO and IV interfaces. Remove caps, connect, open clamp. Eliminates the last point of failure in field plasma delivery. No haemolysis risk.
Dual Luer lock · All standard IO/IV · Pre-primedRAPIDGauze
Holobiont-intact wound packingTCCC-compatible drop-in replacement for QuikClot. Cold-processed sargassum — holobiont intact, native sulphation preserved. Haemostasis. Then MRSA-active antimicrobial. Then NF-κB anti-inflammatory activity. Then wound healing initiation. Simultaneously. From application.
TCCC drop-in · MRSA-active · Biologically active after haemostasisSENTINEL
Battlefield biosensor meshAutonomous mesh-networked vital signs monitoring. Distributed sensor array — TCCC-capable, pre-evacuation triage support. Unit-level medical picture without a medic present. Companion system to the RAPID Family — once the protocol is executed, SENTINEL monitors while evacuation is coordinated.
Mesh network · Autonomous broadcast · Pre-evacuation triageVANTAGE
Voice-first execution layer — military configurationBrowser-based. Any device with a camera and microphone. No app to certify. Token-gated military access — completely isolated from civilian product. 19 languages auto-detected. Operator role: terse, military reporting formats (SALUTE, CONTACT, SITREP). Medic role: nine-line MEDEVAC output. Up to 10,000 device tokens per batch. Surgical revocation at device or unit level via single API call.
No app certification · Token-gated · 19 languages · Live demo availableDonor Identification
SDICS.
SAFE DONOR ID.
The Soldier Donor Identification and Compatibility System. Walking blood bank enablement in peer adversary mass-casualty environments. Cold chain fails at scale — SDICS enables safe buddy-to-buddy blood donation with zero clinician involvement.
Blood type verification. Donor eligibility screening. Crossmatch risk mitigation. Transfusion event logging. Unit-level compatibility data accessible to the medic who eventually arrives — not just at the point of care but as a documented record for forward medical facilities.
Integrated Protocol · SUCCESS.ION GB2607848.5
ASCENT.
MEDICAL AUTHORITY CONTINUITY.
ASCENT is the protocol that answers a question the MoD has not formally resolved in doctrine: what happens to medical authority when the medic is the casualty, in a peer adversary contact, where radio silence is non-negotiable and the patrol cannot stop fighting.
Four systems — SENTINEL, SDICS, VANTAGE, HEARTBEAT — integrated into a single competency-aware, noise-disciplined medical authority continuity protocol powered by SUCCESS.ION (GB2607848.5, filed 5 April 2026). The patrol never has zero medical authority. The system degrades gracefully through defined failover states, each one logged, each one reported to Line 2 at the earliest safe opportunity. No radio call. No audio alert. No pause in the fight.
ASCENT — Full protocol →UKDI Submission
PROCUREMENT
TIMELINE.
UK Defence and Security Accelerator (UKDI) submission window now open. Innovation Outline due 19 May 2026. Full submission 2 June 2026. £750K–£1.2M. TRL 3→7 over 18 months.
UKDI Innovation Outline
Innovation Outline submission. High-level capability description, problem statement, proposed solution approach, team credentials, and initial TRL assessment. NDA-protected technical detail available to qualified UKDI contacts on request.
UKDI Full Submission
Full submission. Complete technical package, clinical data, IP schedule, development roadmap, team structure, cost breakdown. £750K–£1.2M ask. TRL 3→7 target over 18 months. Clinical co-investigator: Prof Steven Jeffery (NDA signed).
Pre-Clinical Validation Programme
Porcine haemorrhagic shock model validation of full RAPID protocol. Ex vivo tissue testing of RAPIDGauze holobiont compound profile. SDICS compatibility algorithm validation. Target: complete preclinical dataset for Phase I regulatory pathway.
Phase I Clinical Programme
Phase I safety and tolerability for RAPIDPen (TXA + ketamine dosing). Human factors validation for RAPIDPlasma frangible-membrane activation in field conditions. Regulatory submission pathway through MHRA/EMA for CE marking. Battlefield medicine regulatory fast-track applicable.
TRL 7 — System Prototype Demonstration
Full system prototype demonstration in operationally representative environment. RAPID protocol validated by non-clinical operators. SENTINEL mesh demonstrated at squad level. SDICS walking blood bank scenario exercised. Procurement recommendation package delivered to MoD/UKDI.
Procurement Specification
PROGRAMME
OVERVIEW.
| Parameter | Detail |
|---|---|
| Programme | UK Defence Innovation (UKDI) — Battlefield Medical Technology |
| Innovation Outline | 19 May 2026 |
| Full Submission | 2 June 2026 |
| Ask | £750,000 – £1,200,000 |
| TRL at submission | TRL 3 (proof of concept demonstrated) |
| TRL target | TRL 7 (system prototype demonstrated in operational environment) |
| Programme duration | 18 months |
| Clinical lead | Prof Steven Jeffery — NDA signed |
| IP status | NTL-001/002/003/004 · GB2606416.2 — UK patent applications filed March 2026 |
| Regulatory pathway | MHRA Class III (RAPIDPen) · CE marking · Battlefield medicine fast-track applicable |
| ASCENT Protocol | Medical Authority Continuity Protocol. Powered by SUCCESS.ION (GB2607848.5, filed 5 April 2026). Integrates SENTINEL, SDICS, VANTAGE, HEARTBEAT. Competency-aware automatic failover when medic is casualty. Rank-gated qualification hierarchy. Silent promotion — visual only, no audio in contact. Biometric-authenticated self-designation with tiered confirmation gateway for occupied roles. Coercion detection via VANTAGE multimodal baseline monitoring. Unbroken chain of medical authority under any casualty scenario. Full protocol → |
| VANTAGE Military | Browser-based voice execution layer. Token-gated. Operator (SALUTE/CONTACT/SITREP) and Medic (nine-line MEDEVAC) roles. 19 languages auto-detected. Batch token provisioning to MDM. Built and operational. No app certification required. Full specification → |
| NATO applicability | STANAG 2939 TCCC alignment · Drop-in replacement for existing haemostatic gauze |
| NDA | Full technical package available under NDA to qualified procurement contacts |
Procurement Contact — NDA Available
NDA-PROTECTED
TECHNICAL DETAIL
ON REQUEST.
Full mechanism data, preclinical package, device engineering specifications, IP schedule, regulatory pathway assessment, clinical team credentials, and UKDI submission documentation are available to qualified MoD, UKDI, NATO, and prime contractor procurement contacts under NDA. Contact directly — no gatekeeping, no account management, no intermediary.
Kirk Harper — Founder, NeuroSync Technologies Limited